B. Braun Settles IV Tylenol IP Row After Losing Venue Fight
A subsidiary of B. Braun Melsungen AG has settled Mallinckrodt IP's multiple patent infringement lawsuits in Delaware federal court seeking to block the German pharmaceutical giant from making generic versions of...To view the full article, register now.
Already a subscriber? Click here to view full article